Numen. Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
Numen. General Information
Description
Provider of home cancer testing services intended to identify prostate, bladder, and ovarian cancers. The company uses synthetic biology and artificial intelligence technology to reliably detect cancer biomarkers, enabling patients to get proper treatment and cancer diagnostics services at ease in their homes.
Contact Information
Website
www.numen.comCorporate Office
- 350 Parnassus Avenue
- Suite 300
- San Francisco, CA 94117
- United States
Corporate Office
- 350 Parnassus Avenue
- Suite 300
- San Francisco, CA 94117
- United States
Numen. Timeline
Numen. Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 01-Oct-2025 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 28-Oct-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jul-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2022 | $346K | Completed | Generating Revenue | ||
| 1. Angel (individual) | 20-Aug-2021 | $346K | $346K | Completed | Generating Revenue |
Numen. Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Numen. Patents
Numen. Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136775-A1 | Class 2, type vi cas enzymes | Pending | 19-Dec-2024 | ||
| WO-2026036091-A1 | Methods, systems and compositions for analyte detection | Pending | 09-Aug-2024 |
Numen. Signals
Numen. Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mayo Clinic Platform | Accelerator/Incubator | |||
| TQ Ventures | Venture Capital | Minority | ||
| Urban Innovation Fund | Venture Capital | Minority | ||
| Y Combinator | Accelerator/Incubator | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator |
Numen. FAQs
-
When was Numen. founded?
Numen. was founded in 2021.
-
Where is Numen. headquartered?
Numen. is headquartered in San Francisco, CA.
-
What is the size of Numen.?
Numen. has 19 total employees.
-
What industry is Numen. in?
Numen.’s primary industry is Other Healthcare Technology Systems.
-
Is Numen. a private or public company?
Numen. is a Private company.
-
What is Numen.’s current revenue?
The current revenue for Numen. is .
-
How much funding has Numen. raised over time?
Numen. has raised $846K.
-
Who are Numen.’s investors?
Mayo Clinic Platform, TQ Ventures, Urban Innovation Fund, Y Combinator, and Creative Destruction Lab have invested in Numen..
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process